Skip to main content

Table 5 Changes in proportions of different primary drug-resistant mycobacterium tuberculosis subgroups, Shandong, China, 2004–2018a

From: Primary drug resistance of mycobacterium tuberculosis in Shandong, China, 2004–2018

Subgroups

X 2

P value

R 2

X-coefficient

SE

MR-TB (%)

6.287

0.012

0.1780

− 0.0073

0.6852

MDR-TB (%)

5.376

0.020

0.2034

0.0051

0.1221

PDR-TB (%)

0.933

0.334

0.0505

0.0022

0.1927

15–44 years(%)

0.673

0.412

0.0822

−0.0026

0.4504

45–64 years(%)

2.837

0.092

0.2046

0.0045

0.3077

> 65 years(%)

0.506

0.477

0.0399

−0.0020

0.2402

Male (%)

12.570

P < 0.001

0.4834

0.0081

0.7595

Female (%)

12.570

P < 0.001

0.4834

−0.0081

0.2405

Cavity (%)

120.530

P < 0.001

0.7022

0.0255

0.1202

Non-cavity (%)

120.530

P < 0.001

0.7244

−0.3673

0.8358

Smoking (%)

0.392

0.531

0.6400

0.0179

−0.0268

Non-smoking (%)

0.392

0.531

0.7506

0.0551

−0.0996

Drinking (%)

0.194

0.659

0.5352

0.0147

−0.0229

Non-drinking (%)

0.194

0.659

0.7634

0.0571

−0.1006

INH (%)

14.725

P < 0.001

0.4269

−0.0112

0.6600

RFP (%)

16.785

P < 0.001

0.5355

0.0101

0.1416

EMB (%)

0.746

0.388

0.0300

0.0012

0.0659

SM (%)

22.076

P < 0.001

0.5365

0.0133

0.5620

  1. INH (%), RFP (%), EMB (%), and SM (%) refer to the proportion of primary INH/RFP/EMB/SM resistant TB among total primary DR TB cases, respectively
  2. aEMB Ethambutol, INH Isoniazid, RIF Rifampin, SM Streptomycin, TB Tuberculosis
  3. MR-TB Mono-resistant tuberculosis, MDR-TB Multi-resistant tuberculosis, PDR-TB Polydrug resistant tuberculosis, EMB Ethambutol, INH Isoniazid, RFP Rifampin, SM Streptomycin